SEC CIK 1260073
CATANIA ANGELO
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| OCFCview stock → | 38,683 | 2022-02-28 |
Position History — OCFC
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — OCFC
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2022-02-28 | Grant / award | 2,235 | $0.00 | 38,683 |
| 2022-02-11 | Option exercise (derivative) | 3,500 | $13.83 | 0 |
| 2022-02-11 | Tax withholding | 2,170 | $22.31 | 36,417 |
| 2022-02-11 | Option exercise | 3,500 | $13.83 | 38,587 |
| 2021-02-26 | Grant / award | 2,301 | $0.00 | 34,993 |
| 2021-01-14 | Option exercise (derivative) | 3,500 | $0.00 | 0 |
| 2021-01-14 | Option exercise | 3,500 | $13.87 | 35,025 |
| 2021-01-14 | Tax withholding | 2,362 | $20.56 | 32,663 |
| 2020-02-28 | Grant / award | 2,445 | $0.00 | 31,398 |
| 2020-02-11 | Option exercise (derivative) | 3,310 | $10.00 | 0 |
| 2020-02-11 | Option exercise | 3,310 | $10.00 | 30,332 |
| 2020-02-11 | Tax withholding | 1,407 | $23.53 | 28,925 |
| 2019-02-28 | Grant / award | 1,190 | $0.00 | 26,940 |
| 2019-02-11 | Option exercise (derivative) | 2,363 | $12.28 | 0 |
| 2019-02-11 | Tax withholding | 1,157 | $25.09 | 25,726 |
| 2019-02-11 | Option exercise | 2,363 | $12.28 | 26,883 |
| 2018-03-12 | Option exercise (derivative) | 2,363 | $0.00 | 0 |
| 2018-02-15 | Option exercise | 2,363 | $16.81 | 25,942 |
| 2018-02-15 | Open-market sale | 1,505 | $26.47 | 24,437 |
| 2018-02-15 | Option exercise (derivative) | 2,363 | $16.81 | 0 |
| 2018-02-15 | Open-market sale | 1,505 | $26.47 | 24,364 |
| 2018-02-15 | Option exercise | 2,363 | $16.81 | 25,869 |
| 2018-01-24 | Grant / award | 1,095 | $0.00 | 23,506 |
| 2017-03-15 | Grant / award | 1,335 | $0.00 | 22,649 |
| 2017-03-15 | Grant / award | 1,035 | $0.00 | 22,349 |
| 2016-12-01 | Option exercise (derivative) | 2,250 | $0.00 | 0 |
| 2016-12-01 | Open-market sale | 1,994 | $25.12 | 21,296 |
| 2016-12-01 | Option exercise | 2,250 | $22.50 | 23,290 |
| 2016-03-16 | Grant / award | 1,740 | $0.00 | 20,968 |
| 2015-03-18 | Grant / award | 1,850 | $0.00 | 19,131 |
| 2014-03-19 | Grant / award | 1,880 | $0.00 | 17,183 |
| 2013-02-15 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2013-02-15 | Grant / award | 713 | $0.00 | 15,210 |
| 2012-02-15 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2012-02-15 | Grant / award | 681 | $0.00 | 14,325 |
| 2011-02-18 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2011-02-18 | Grant / award | 796 | $0.00 | 13,513 |
| 2010-10-27 | Open-market buy | 2,000 | $12.10 | 12,717 |
| 2010-02-26 | Open-market buy | 500 | $10.15 | 10,717 |
| 2010-02-17 | Grant / award (derivative) | 3,310 | $0.00 | 3,310 |
| 2010-02-17 | Grant / award | 605 | $0.00 | 10,217 |
| 2010-01-27 | Open-market buy | 3,000 | $10.44 | 9,612 |
| 2009-02-18 | Grant / award (derivative) | 2,363 | $0.00 | 2,363 |
| 2009-02-18 | Grant / award | 355 | $0.00 | 1,175 |
| 2008-11-21 | Open-market buy | 502 | $12.86 | 5,014 |
| 2008-11-21 | Open-market buy | 498 | $12.85 | 4,512 |
| 2008-03-03 | Open-market buy | 125 | $16.01 | 4,014 |
| 2008-03-03 | Open-market buy | 300 | $16.00 | 3,889 |
| 2008-03-03 | Open-market buy | 75 | $15.98 | 3,589 |
| 2008-02-20 | Grant / award (derivative) | 2,363 | $0.00 | 2,363 |
| 2008-02-20 | Grant / award | 335 | $0.00 | 1,045 |
| 2007-05-08 | Open-market buy | 1,381 | $17.53 | 3,000 |
| 2007-05-08 | Open-market buy | 200 | $17.48 | 1,200 |
| 2007-05-08 | Open-market buy | 419 | $17.53 | 1,619 |
| 2007-02-21 | Grant / award (derivative) | 2,250 | $0.00 | 2,250 |
| 2007-02-21 | Grant / award | 434 | $0.00 | 1,210 |
| 2006-04-20 | Grant / award | 431 | $0.00 | 431 |
| 2006-02-15 | Grant / award (derivative) | 3,000 | $0.00 | 3,000 |
| 2006-02-15 | Grant / award | 352 | $0.00 | 352 |
| 2006-01-18 | Grant / award | 1,000 | $0.00 | 1,000 |
| 2006-01-18 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.